S. Anai

S. Anai, M. Takeshita, Shohei Mishima, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Fernando Maciel Barbosa, Raymond J. McDermott, J. Burke, 2022, The Lancet. Oncology.

The diagnostic utility of retroperitoneoscopic tissue biopsy for unresectable retroperitoneal lesions excluding urogenital cancers

S. Anai, M. Miyake, N. Tanaka, 2019, World Journal of Surgical Oncology.

Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma

K. Shimada, S. Anai, N. Konishi, 2011, British Journal of Cancer.

CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer123

T. Kishimoto, K. Shimada, S. Anai, 2016, Neoplasia.

Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth

W. Cai, S. Goodison, S. Anai, 2019, Theranostics.

Combination of PTEN gene therapy and radiation inhibits the growth of human prostate cancer xenografts.

K. Iczkowski, S. Goodison, S. Anai, 2006, Human gene therapy.

ALKBH3 Contributes to Survival and Angiogenesis of Human Urothelial Carcinoma Cells through NADPH Oxidase and Tweak/Fn14/VEGF Signals

K. Shimada, S. Anai, K. Tsujikawa, 2012, Clinical Cancer Research.

ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder

K. Shimada, S. Anai, N. Konishi, 2011, BMC urology.

Proposed salvage treatment strategy for biochemical failure after radical prostatectomy in patients with prostate cancer: a retrospective study

S. Anai, N. Konishi, M. Hasegawa, 2014, Radiation oncology.

Effect of Prolonged Duration of Transrectal Ultrasound-Guided Biopsy of the Prostate and Pre-Procedure Anxiety on Pain in Patients without Anesthesia

C. Ohbayashi, S. Anai, M. Miyake, 2021, Research and reports in urology.

RRU_A_297703 111..120

C. Ohbayashi, S. Anai, M. Miyake, 2021 .

Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study)

Takashi Inoue, S. Anai, Shota Suzuki, 2021, Trials.

Positive surgical margins at radical prostatectomy: importance of intra-operative bladder neck frozen sections.

S. Anai, C. Rosser, John Pendleton, 2007, International braz j urol : official journal of the Brazilian Society of Urology.

Efficacy of medical expulsive therapy using the traditional Japanese medicine (kampo) choreito for the spontaneous passage of proximal ureteric stones: A retrospective analysis

S. Anai, M. Miyake, N. Tanaka, 2022, Traditional & Kampo Medicine.

Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma

S. Anai, M. Miyake, N. Tanaka, 2021, Clinical Genitourinary Cancer.

Clinical Impact of Sarcopenia and Inflammatory/Nutritional Markers in Patients with Unresectable Metastatic Urothelial Carcinoma Treated with Pembrolizumab

S. Anai, M. Miyake, N. Tanaka, 2020, Diagnostics.

Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer.

Wengang Cao, S. Goodison, S. Anai, 2011, Urologic oncology.

Coincidence of immunotherapy-associated hemophagocytic syndrome and rapid tumor regression.

S. Anai, S. Mishima, M. Takeshita, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Splenic volume in pneumococcal pneumonia patients is associated with disease severity and mortality.

S. Anai, T. Takao, R. Ibusuki, 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization.

S. Goodison, S. Anai, C. Rosser, 2007, Urology.

A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.

S. Anai, M. Miyake, N. Tanaka, 2018, Anticancer research.

Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy

K. Shimada, S. Anai, N. Konishi, 2017, Oncology.

Clinical significance of α‑ and β‑Klotho in urothelial carcinoma of the bladder.

S. Anai, M. Miyake, N. Tanaka, 2016, Oncology reports.

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model

S. Anai, M. Miyake, N. Tanaka, 2013, BMC Urology.

Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy

K. Shimada, S. Anai, M. Miyake, 2019, International Journal of Clinical Oncology.

Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens

S. Anai, H. Furuya, C. Rosser, 2019, Cells.

PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements.

Y. Oda, S. Anai, Y. Nakanishi, 2018, Lung cancer.

Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid

S. Anai, M. Miyake, N. Tanaka, 2018, Lasers in Medical Science.

Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas

K. Shimada, S. Anai, N. Konishi, 2016, World Journal of Surgical Oncology.

External validation of the albumin, C-reactive protein and lactate dehydrogenase model in patients with metastatic renal cell carcinoma receiving second-line axitinib therapy in a Japanese multi-center cohort.

H. Miyake, S. Anai, A. Yokomizo, 2021, Japanese journal of clinical oncology.

Successful Diagnosis by Video-Assisted Thoracoscopic Surgical Lung Biopsy in a Case of Progressive Primary Pulmonary Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Case Report

S. Anai, A. Gakiya, M. Kiyuna, 2023, Cureus.

URETHROPLASTY FOR COMPLICATED ANTERIOR URETHRAL STRICTURES.

S. Anai, Katsunori Yoshida, M. Miyake, 2016, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Initial experience of complete laparoscopic radical nephroureterectomy combined with transvesical laparoscopic excision of distal ureter in patients with upper urinary tract cancer

S. Anai, M. Miyake, N. Tanaka, 2020, World Journal of Surgical Oncology.

Video‐urodynamic effects of vibegron, a new selective β3‐adrenoceptor agonist, on antimuscarinic‐resistant neurogenic bladder dysfunction in patients with spina bifida

S. Anai, M. Miyake, N. Tanaka, 2021, International journal of urology : official journal of the Japanese Urological Association.

Trends in treatment outcomes of hydrocele in Japanese children: A single‐institute experience

S. Anai, M. Miyake, N. Tanaka, 2020, International journal of urology : official journal of the Japanese Urological Association.

Exploration of risk factors predicting outcomes for primary T1 high‐grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long‐term follow‐up experience at a single institute

K. Shimada, S. Anai, N. Konishi, 2015, International journal of urology : official journal of the Japanese Urological Association.

Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.

S. Goodison, S. Anai, Motoyoshi Tanaka, 2007, The Journal of urology.

Living‐donor kidney transplantation for a patient with hypoparathyroidism, deafness, and renal dysplasia syndrome

S. Anai, M. Miyake, N. Tanaka, 2020, IJU case reports.

1-tert-Butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a Selective Tyrosine Kinase Inhibitor of Fibroblast Growth Factor Receptor-3 (FGFR3), Inhibits Cell Proliferation of Bladder Cancer Carrying the FGFR3 Gene Mutation along with Up-Regu

S. Anai, M. Miyake, K. Fujimoto, 2010, Journal of Pharmacology and Experimental Therapeutics.

Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.

S. Anai, M. Hasegawa, M. Miyake, 2011, Japanese journal of clinical oncology.

ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression

K. Shimada, S. Anai, N. Konishi, 2013, Cancer science.

Chromophobe cell renal carcinoma with acquired cystic disease of the kidney in a long‐term hemodialysis patient

S. Anai, Katsunori Yoshida, E. Okajima, 2003, International journal of urology : official journal of the Japanese Urological Association.

Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.

S. Anai, M. Miyake, N. Tanaka, 2015, Photodiagnosis and photodynamic therapy.

Trends in primary treatment for localized prostate cancer according to the availability of treatment modalities and the impact of introducing robotic surgery

S. Anai, M. Miyake, N. Tanaka, 2022, International journal of urology : official journal of the Japanese Urological Association.

Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy

K. Shimada, S. Anai, N. Marugami, 2018, Supportive Care in Cancer.

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer

S. Anai, M. Hasegawa, M. Miyake, 2019, Journal of contemporary brachytherapy.

Prostate cancer knowledge and screening attitudes of inner-city men

S. Anai, C. Rosser, John Pendleton, 2008, Journal of Cancer Education.

Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria

K. Iczkowski, S. Anai, C. Rosser, 2009, BMC urology.

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid

S. Anai, Katsunori Yoshida, M. Miyake, 2014, BMC Urology.

[Reversed halo sign in organizing pneumonia secondary to Sjögren syndrome].

S. Anai, Y. Nakanishi, H. Kumazoe, 2011, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

S. Anai, M. Miyake, N. Tanaka, 2016, BMC Research Notes.

Hexylaminolevulinate‐mediated fluorescent urine cytology with a novel automated detection technology for screening and surveillance of bladder cancer

S. Anai, M. Miyake, N. Tanaka, 2021, BJU international.

Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method

S. Anai, M. Miyake, N. Tanaka, 2021, Diagnostics.

Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.

S. Anai, Takeshi Inoue, M. Miyake, 2011, Oncology reports.

Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient’s age and prostate volume

S. Anai, N. Konishi, M. Miyake, 2019, Research and reports in urology.

Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil

S. Anai, M. Hasegawa, M. Miyake, 2021, International journal of urology : official journal of the Japanese Urological Association.

Non-ischemic, Non-renorrhaphy Laparoscopic Partial Nephrectomy Using a Microwave Tissue Coagulator for Small Renal Tumors

S. Anai, E. Okajima, M. Miyake, 2016 .

A prospective, single-arm trial of fluorescent ureteroscopy-assisted thulium-holmium:YAG dual laser ablation for upper urinary tract cancer: Study protocol of the FLUAM trial

S. Anai, M. Miyake, N. Tanaka, 2022, Contemporary clinical trials communications.

The Sustaining of fluorescence in photodynamic diagnosis after the administration of 5-aminolevulinic acid in carcinogen-induced bladder cancer orthotopic rat model and urothelial cancer cell lines.

S. Anai, H. Kuniyasu, M. Miyake, 2021, Photodiagnosis and photodynamic therapy.

Cyclooxygenase 2-dependent and independent activation of Akt through casein kinase 2α contributes to human bladder cancer cell survival

K. Shimada, S. Anai, N. Konishi, 2011, BMC urology.

ALKBH 3 Contributes to Survival and Angiogenesis of Human Urothelial Carcinoma Cells through NADPH Oxidase and Tweak / Fn 14 / VEGF Signals

K. Shimada, S. Anai, N. Konishi, 2012 .

Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute

S. Anai, N. Konishi, M. Hasegawa, 2017, BMC Urology.

Efficacy and Safety of First-Line Cytokines versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study

S. Anai, N. Kawai, K. Ishibashi, 2023, Cancers.

Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data

S. Anai, M. Miyake, N. Tanaka, 2022, Cancer management and research.

Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder

K. Shimada, S. Anai, N. Marugami, 2017, BMC Cancer.

Insignificant role of bacillus Calmette–Guérin maintenance therapy after complete transurethral resection of bladder tumor for intermediate‐ and high‐risk non‐muscle‐invasive bladder cancer: Results from a randomized trial

S. Anai, N. Konishi, N. Tanaka, 2016, International journal of urology : official journal of the Japanese Urological Association.

Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma: Japanese patients from the CLEAR study

S. Anai, M. Oya, Yoshihiko Tomita, 2022, Cancer medicine.

Coincidence of immunotherapy-associated hemophagocytic syndrome and rapid tumor regression.

S. Anai, S. Mishima, M. Takeshita, 2017 .

Prostate-specific antigen bounce after 125I-brachytherapy for prostate cancer is a favorable prognosticator in patients who are biochemical recurrence-free at 4 years and correlates with testosterone.

S. Anai, M. Hasegawa, M. Miyake, 2020, Japanese journal of clinical oncology.

A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study

C. Ohbayashi, Takashi Inoue, S. Anai, 2020, Contemporary clinical trials communications.

ALA-induced fluorescence detection with photoresist-based microfluidic cell sorter for bladder cancer diagnosis☆

Toshiyuki Tsuchiya, Yoshikazu Hirai, Osamu Tabata, 2015 .

Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy

S. Anai, N. Konishi, M. Miyake, 2017, BMC Urology.

The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions

S. Anai, N. Konishi, M. Hasegawa, 2018, Prostate international.

BCL-2 MEDIATED MODULATION OF VASCULARIZATION IN PROSTATE CANCER XENOGRAFTS

Wengang Cao, S. Goodison, S. Anai, 2009 .

Bcl‐2 mediated modulation of vascularization in prostate cancer xenografts

Wengang Cao, S. Goodison, S. Anai, 2009, The Prostate.

Comparison of chronological changes in urinary function in patients who underwent low-dose-rate brachytherapy for prostate cancer-A randomized controlled trial of alpha-1 adrenoceptor antagonist alone versus combination with cyclooxygenase-2 inhibitor.

S. Anai, M. Hasegawa, M. Miyake, 2018, Brachytherapy.

Factors affecting urinary frequency after low‐dose‐rate brachytherapy for prostate cancer

S. Anai, M. Hasegawa, M. Miyake, 2021, Lower urinary tract symptoms.

Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer

S. Anai, N. Konishi, M. Hasegawa, 2017, BMC Cancer.

Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

S. Anai, N. Konishi, M. Hasegawa, 2014, Radiation oncology.

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer

S. Anai, N. Konishi, M. Hasegawa, 2018, Clinical and translational radiation oncology.

Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer

S. Anai, M. Hasegawa, M. Miyake, 2018, Journal of radiation research.

S. Anai, N. Konishi, M. Miyake, 2017, BMC Cancer.

Response to flutamide, as second-line therapy after bicalutamide, predicts efficacy of abiraterone, not that of enzalutamide

S. Anai, M. Miyake, N. Tanaka, 2018, BMC Research Notes.

Erectile dysfunction and sexual quality of life in patients who underwent low‐dose‐rate brachytherapy alone for prostate cancer

S. Anai, M. Hasegawa, M. Miyake, 2021, Andrologia.

Minimal percentage of dose received by 90% of the urethra (%UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer

S. Anai, N. Konishi, M. Hasegawa, 2012, BMC Urology.

The Feasibility of Expectant Management with Inner-city Men with Newly Diagnosed Localized Prostate Cancer

S. Anai, C. Rosser, John Pendleton, 2008, Journal of health care for the poor and underserved.

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists

K. Shimada, S. Anai, N. Konishi, 2015, BMC Urology.

Prostate cancer screening and detection in inner-city and underserved men.

S. Anai, P. Wludyka, C. Pettaway, 2006, Journal of the National Medical Association.

Trends in risk classification at diagnosis and choice of primary therapy for prostate cancer: An analysis of 10 839 patients from the Nara Urological Research and Treatment Group registry between 2004 and 2015

S. Anai, M. Miyake, N. Tanaka, 2021, International journal of urology.

Efficacy and safety of cytokines versus first-line sunitinib and second-line axitinib for patients with metastatic renal cell carcinoma (ESCAPE study): A study protocol for phase III randomized sequential open-label study

S. Anai, N. Kawai, K. Ishibashi, 2019, Contemporary clinical trials communications.

Erratum to: Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder

K. Shimada, S. Anai, N. Marugami, 2017, BMC Cancer.

Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer.

S. Anai, N. Konishi, M. Hasegawa, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram

K. Shimada, S. Anai, N. Konishi, 2015, BMC Research Notes.

Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.

S. Goodison, S. Anai, Motoyoshi Tanaka, 2007 .

Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder

Youping Deng, K. Shimada, S. Anai, 2020, Diagnostics.

Follow-up study of unilateral renal function after nephrectomy assessed by glomerular filtration rate per functional renal volume

S. Anai, Katsunori Yoshida, N. Tanaka, 2014, World Journal of Surgical Oncology.

Quality of life in patients who underwent robot‐assisted radical prostatectomy compared with those who underwent low‐dose‐rate brachytherapy

S. Anai, M. Hasegawa, M. Miyake, 2023, The Prostate.

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

H. Shiina, S. Anai, A. Yokomizo, 2023, Urologic oncology.

ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression

K. Shimada, S. Anai, N. Konishi, 2013, Cancer science.

S. Anai, M. Miyake, K. Fujimoto, 2010, Journal of Pharmacology and Experimental Therapeutics.

Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy

K. Shimada, S. Anai, M. Miyake, 2019, International Journal of Clinical Oncology.

S. Anai, N. Konishi, N. Tanaka, 2016, International journal of urology : official journal of the Japanese Urological Association.

A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE Trial

S. Anai, M. Miyake, Y. Nakai, 2024, Methods and protocols.

Localized prostate cancer with pelvic arteriovenous malformation treated with low‐dose‐rate brachytherapy after transcatheter embolization: Two case reports

S. Anai, M. Hasegawa, M. Miyake, 2019, IJU case reports.

Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancer

S. Anai, N. Konishi, M. Hasegawa, 2017, BMC Cancer.

URETHROPLASTY FOR COMPLICATED ANTERIOR URETHRAL STRICTURES.

S. Anai, Katsunori Yoshida, M. Miyake, 2016, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

S. Anai, M. Miyake, N. Tanaka, 2018, Oncology.